H.C. Wainwright Reiterates Buy Rating on Solid Biosciences (SLDB)
upgrade
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
upgrade
What happened, with direct paths to the underlying reporting
Target: $25; Posted price: $8.70; Upside ~187%.
Target: $25
Posted price: $8.7
Analyst firm: Loop Capital Markets
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.